NCT05245032View on ClinicalTrials.gov

Biologically Focused Therapy of Treatment-Refractory MDS Patients

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Myelodysplastic Syndromes
Trial Locations (1)

94304

Stanford MDS Center, Stanford

Sponsors

Collaborators (1)

Notable Labs Inc.
All Listed Sponsors
collaborator

Notable Labs Inc.

UNKNOWN

lead

Stanford University

OTHER